Skip to main content

Table 3 Homocysteine levels before and after treatment according to MTHFR C677T genotype

From: A prospective cohort study of MTHFR C677T gene polymorphism and its influence on the therapeutic effect of homocysteine in stroke patients with hyperhomocysteinemia

 

CC (n = 10)

CT (n = 55)

TT (n = 97)

P value*

HCY before treatment, μmol/L

20.26 ± 6.60

18.90 ± 6.37

21.75 ± 8.19

0.049

HCY after treatment, μmol/L

14.02 ± 3.53

12.98 ± 5.01 ab

19.45 ± 11.32 ab

0.002

P value**

0.535

0.328

0.211

 
  1. * Analysis of variance was used for comparison among genotypes
  2. ** Paired sample t-test was used for comparison between baseline and 1 month after treatment
  3. ab Different letters indicate statistical significance. Least significant difference (LSD) test was used for pairwise comparison. CCvsCT p = 0.816; CC vs TT p = 0.215; CT vs TT p = 0.001